A Nationwide Survey on Patient Empowerment in Pediatric Inflammatory Bowel Disease in Germany

Kalina Kaul1, Stefan Schumann1, Cornelia Sander2

  • 1Department of General Pediatrics and Neonatology, University Children's Hospital, University Giessen, 35392 Giessen, Germany.

PubMed

Insights

Pediatric inflammatory bowel disease (IBD) care needs improvement, with young patients lacking crucial information on managing their condition. Empowering children and adolescents with IBD through targeted resources can enhance their health literacy and self-management skills.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Health Literacy in Adolescents

Background:

  • The incidence of pediatric inflammatory bowel disease (IBD) is rising, significantly impacting young patients' development and families.
  • Children and adolescents with IBD require enhanced healthcare support, yet specific needs remain largely unaddressed.
  • A focus on patient empowerment is crucial for improving care for pediatric IBD.

Purpose of the Study:

  • To assess the current state of care and information needs for pediatric IBD patients and their families.
  • To identify deficits in knowledge and support systems for adolescents with IBD.
  • To explore strategies for patient empowerment and improved health literacy in pediatric IBD.

Main Methods:

  • An anonymous survey (CEDNA) was distributed across Germany to adolescents with IBD and their parents.
  • Questionnaires focused on disease coping, healthcare utilization, information access, and preferred communication methods.
  • Data from 1158 completed questionnaires (708 parents, 450 patients) were analyzed.

Main Results:

  • A significant deficit in pediatric IBD care was identified, with substantial knowledge gaps among patients.
  • Key areas of insufficient information include disease transition (74.8%), patient organizations (62.4%), and preventive health measures (54.7%).
  • Results indicate a low level of health literacy concerning IBD among affected children and adolescents.

Conclusions:

  • Pediatric IBD presents multifaceted challenges for patients, families, and healthcare providers.
  • Empowering patients and families with tailored information and communication strategies is essential for improving care.
  • Enhancing online resources, facilitating self-management, and supporting transitions are key actions to better meet patient needs.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
128
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
251
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
199
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
119
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168